While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

President Donald Trump signed an executive order that claims to force Big Medicine to lower prescription drug prices paid by ...

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an ...

UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

New legislation aimed at lowering drug prices could slam American patients and taxpayers with a multibillion-dollar bill instead. The “Delinking Revenue ...

WSJ's Shira Ovide and Jonathan Rockoff discuss Express Scripts' $29.1 billion deal to acquire fellow pharmacy-benefit manager ...

Rite Aid announced it's planning to close stores across New York State and customers in Western New York are looking at other ...

Consumers, doctors and other advocates agree pharmacy benefit managers (PBMs) wield too much power and influence over patients’ access to medicines and their prices.

Health insurance is covering fewer medications, with Medicare patients facing stricter restrictions. Profit-driven ...